• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

EXOSC9 Peptide - Middle Region Blocking Peptide

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS3246816

This is a synthetic peptide designed for use in combination with anti- EXOSC9 Antibody, madeTarget Description: This gene encodes a component of the human exosome, a exoribonuclease complex which processes and degrades RNA in the nucleus and cytoplasm. This… More details

$195 / 0.1 mg +1 FREE 8GB USB
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
EXOSC9, Blocking Peptide
Full Product Name
EXOSC9 Peptide - middle region
Product Gene Name
Product Synonym Gene Name
p5; p6; RRP45; PMSCL1; Rrp45p; PM/Scl-75
Sequence
Synthetic peptide located within the following region: IIAEAEPPSE VVSTPVLWTP GTAQIGEGVE NSWGDLEDSE KEDDEGGGDQ
Species Reactivity
Human
Form/Format
Lyophilized powder
Preparation and Storage
Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20 degree C. Avoid repeat freeze-thaw cycles.
Antibody/Peptide Pairs
EXOSC9 peptide (MBS3246816) is used for blocking the activity of EXOSC9 antibody (MBS3222112)
Molecular Weight
48 kDa
OMIM
606180

Product Categories/Family for EXOSC9 blocking peptide

Other Notes

Small volumes of EXOSC9 blocking peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for EXOSC9 purchase

MBS3246816 is a blocking peptide targeting EXOSC9. Also known as EXOSC9 Peptide - middle region. Reactive in Human.

Additional Details

NCBI/Uniprot data below describe general gene information for EXOSC9. It may not necessarily be applicable to this product.

NCBI GI #
NCBI GeneID
NCBI Accession #
UniProt Primary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
exosome complex component RRP45 isoform 1
NCBI Official Synonym Full Names
exosome component 9
NCBI Official Symbol
EXOSC9
NCBI Official Synonym Symbols
p5; p6; PCH1D; RRP45; PMSCL1; Rrp45p; PM/Scl-75
UniProt Protein Name
Exosome complex component RRP45
UniProt Synonym Protein Names
Autoantigen PM/Scl 1; Exosome component 9; P75 polymyositis-scleroderma overlap syndrome-associated autoantigen; Polymyositis/scleroderma autoantigen 1; Polymyositis/scleroderma autoantigen 75 kDa; PM/Scl-75
UniProt Gene Name
EXOSC9
UniProt Synonym Gene Names
PMSCL1; PM/Scl-75
UniProt Entry Name
EXOS9_HUMAN
NCBI Protein Information
exosome complex component RRP45

NCBI Summary for EXOSC9

This gene encodes a component of the human exosome, a exoribonuclease complex which processes and degrades RNA in the nucleus and cytoplasm. This component may play a role in mRNA degradation and the polymyositis/scleroderma autoantigen complex. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
Show more

UniProt Comments for EXOSC9

EXOSC9: Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes. EXOSC9 binds to ARE-containing RNAs. Belongs to the RNase PH family. 4 isoforms of the human protein are produced by alternative splicing.

Protein type: EC 3.1.13.-; Ribonuclease; RNA processing; Nucleolus

Chromosomal Location of Human Ortholog: 4q27

Cellular Component: nucleoplasm; nuclear chromosome; intermediate filament cytoskeleton; cytoplasm; nucleolus; exosome (RNase complex); nucleus; cytosol; nuclear exosome (RNase complex)

Molecular Function: protein binding; 3'-5'-exoribonuclease activity; exoribonuclease activity; RNA binding; AU-rich element binding

Biological Process: immune response; gene expression; positive regulation of cell growth; rRNA processing; mRNA catabolic process, deadenylation-dependent decay
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Products associated with EXOSC9 blocking peptide

 Reference Product  PubMed Publications
 EXOSC8 blocking peptide  >1 publications with EXOSC9 and EXOSC8

Diseases associated with EXOSC9 blocking peptide

Organs/Tissues associated with EXOSC9 blocking peptide

 Organ/Tissue Name  Pubmed Publications
 Skin Antibodies  >1 publications with EXOSC9 and Skin
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000